Mission: We are dedicated to the research and development of first-in-class therapies for people suffering from debilitating diseases that rob them of key muscle functions. By focusing on improving the mechanics of muscle with investigational medicines that may increase strength, power ...
Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. A leader in muscle biology research with approximately 25 publications, 50 clinical trials, and more than 200 issued patents, Cytokinetics is developing small molecule drug candidates specifically engineered to increase muscle function and contractility.
Cytokinetics was founded by pioneers in the field of muscle biology. Over the years, our company has developed an unparalleled expertise, keeping it at the forefront of drug discovery and development for diseases impacting muscle performance. Muscle plays a critical role in everyday physical functionality, including proper circulation, movement, and even the ability to breathe. As a result, conditions or syndromes that lead to dysfunction of muscle have serious consequences on survival and well-being.
Cytokinetics takes a purpose-driven approach by leveraging our unique muscle biology expertise to engineer compounds with specific characteristics aimed at treating diseases that impact muscle function. By increasing muscle strength and performance, the treatments we are developing have the potential to preserve and extend independence and self-reliance in people suffering from debilitating diseases. Cytokinetics is dedicated to helping underserved patient populations which lack effective therapies.
Cytokinetics scientists have discovered a robust pipeline of small molecule muscle activators including tirasemtiv, our Phase 3 drug candidate for people living with ALS; omecamtiv mecarbil, our Phase 3 drug candidate for people living with heart failure; and CK-2127107 (CK-107), our Phase 2 drug candidate for people living with SMA and COPD. Our muscle biology drug discovery and development platform has great potential for many other diseases and medical conditions characterized by muscle weakness, fatigue, or diminished muscle function.
We are fortunate to work in an industry with such an important purpose and believe it is a privilege to participate and dedicate one’s career to such a meaningful calling. We strive to provide more than a job; instead, we expect Cytokinetics will be a place you come to stay, because it fulfills your personal motivations and desires to contribute to something bigger than any one of us. We appreciate that company culture is something that constantly evolves and is ultimately tied to our day-to-day interactions. However, we believe it is critical to articulate what is important to us, how we will commit to treat and respect each other, and what we want to foster and encourage. We acknowledge that some aspects of our still evolving culture are more developed while others are more aspirational. However, this reflects our “stake in the ground” to guide us, hold us accountable, and celebrate examples of that which we hold as important to us.
Innovation is at the heart of Cytokinetics’ mission. We take pride in the pursuit of innovative approaches to novel research and development. While our approach is more challenging, carries higher risks, and can be humbling at times, we wouldn’t trade it for anything.
We recognize that the complexities of our novel pursuits will foster discussion and possibly differing opinions, resulting in passionate convictions and healthy debates from all levels and functional areas. We also expect and take pride in transparent and candid dialogue with and among all employees. Critical and bold thinking enables us to achieve our goals.
INTEGRITY & RESPECT
We expect ethical behavior, high integrity, and mutual respect from all employees. Although opinions may differ, the focus must remain on solving the issue or challenge at hand while maintaining a respectful atmosphere. We are strongest when we function as a unified team.
GOALS & ACCOUNTABILITY
We are aggressive in setting challenging goals as well as measuring and communicating our performance and execution toward them. We also recognize that our objectives may require adjustment with new information or data. We have high expectations regarding commitment, dedication, ownership, and accountability for outcomes.
We ask a lot of our employees. Cytokinetics is not the place to work if you are seeking an easy, predictable, and comfortable job. At the same time, we offer flexible solutions for how the job can be performed and strive to afford reasonable work/life balance for all employees. We strive for realistic expectations but recognize that success in our business requires extraordinary dedication and commitment to excellence.
We view employee development as mutually beneficial and a shared responsibility. We expect employees to be challenged, afforded the opportunity to develop new skills, and given every opportunity to excel but also allowed to fail. We foster an environment where employees can learn from their missteps and facilitate an environment of personal and professional development, growth, and advancement.
A FUN COMMUNITY
We are proud of fostering a strong sense of community in which our employees develop strong bonds with colleagues. We provide many opportunities to mix work and social connections and believe a “work hard, play hard” attitude is critical to building and sustaining a positive and invigorating culture. We also believe that we have a corporate and social responsibility to give back to the broader community in which we operate through volunteerism and support of the patient populations we serve.
We view our employees as the unequivocal ingredients to success. Each and every employee is an integral member of the Cytokinetics team, contributing to our shared goal of improving the lives of people with debilitating diseases in which muscle performance is compromised and/or declining. While expectations of our employees are high, there is an equal commitment to ensuring that contributions are recognized and rewarded. We seek exceptional individuals to join us in our mission to develop the next generation of novel small molecule drugs specifically engineered to increase muscle function and contractility.
Our passion is anchored in rigorous and diligent scientific and clinical approaches to the discovery and development of novel mechanism therapeutics. With gratitude for the commitments and convictions of our employees who are inspired by the courage of patients we aim to serve, we believe Cytokinetics will continue to be a pioneering, values-driven, sustainable, fully integrated biopharmaceutical company.
We are inspired by the unmet medical needs of patients as well as the suffering of their loved ones and we believe our primary purpose is to make a meaningful difference in their lives. We are confident that by keeping the patients as our top priority, we cannot lose our way and that it will ensure we do the right thing by all of our stakeholders.
I have been working at Cytokinetics full-time (Less than a year)
Cytokinetics is very committed to the community with ample opportunities for community service throughout the year. They are equally committed to the patient populations we are developing treatments for.
Not all areas are as collaborative as they could be.
I applied through an employee referral. I interviewed at Cytokinetics (South San Francisco, CA) in August 2017.
I gave a 30 min PowerPoint given to a diverse group of ~20 employees on my dissertation and postdoctoral work researching cardiovascular physiology and pathology. This was followed by one-on-one interviews with each member of the team. The the HR coordinator called the next day to negotiate salary and this information was forwarded to the temp agency who offered the contract. They were very direct and efficient.
Let us know if we're missing any workplace or industry recognition –